Bioelectronic medicine is the convergence of biology and electrical engineering. The human body is an electrochemical system. Bioelectronic devices work by modulating the electrical activity in peripheral and central nerves in order to mitigate both symptoms and underlying causes of disease.
Neuromodulation is another term commonly used to describe technologies that modulate nerve activity in the central nervous system or the peripheral nervous system using electrical current, magnetism, or other stimuli.
Neuromodulation in the Market
Neuromodulation is a $6.2 Billion global market. Devices in this market include the pacemaker for cardiac arrhythmia, deep brain stimulator for Parkinsonian tremor, spinal cord stimulator for chronic pain, and transcranial magnetic stimulation for drug-resistant major depressive disorder. Both implantable and non-invasive devices are being developed for a number of new applications including the treatment of a migraine, rheumatoid arthritis, and Crohn’s disease.
Tivic Health and Bioelectronics
Tivic Health is a state-of-the-art bioelectronics medical device company that is dedicated to bringing innovative therapies that are accessible and affordable for home-use. Tivic Health Systems was founded in 2016 by co-founder Jennifer Ernst, a high-tech business builder and John Claude, a biomedical engineer. After robust designing, testing and retesting, Tivic Health has developed a first-of-kind device, named ClearUP Sinus Pain Relief, that is ground-breaking.
ClearUP Sinus Pain Relief
ClearUP Sinus Pain Relief, our first bioelectronic consumer device, uses advanced microcurrent technology to treat sinus pain for those with allergies. This microcurrent (low-current electrical stimulation) technology falls under bioelectronics, one of the top ten emerging health trends that delivers drug-free medicine through the use of neuromodulation to effectively treat a variety of chronic conditions.